Browsing Category
Pharma Industry News
4765 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Oxford Biomedica eyes ABL Europe acquisition to bolster cell and gene therapy CDMO operations
Oxford Biomedica plc and Institut Mérieux SA have entered exclusive negotiations concerning Oxford Biomedica’s proposed acquisition of ABL…
Zydus Lifesciences gets FDA green light for acne treatment gel
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) for its…
EC approves Cabotegravir LA by ViiV Healthcare for HIV prevention
ViiV Healthcare, majorly owned by GSK with Pfizer and Shionogi as shareholders, announced that the European Commission (EC)…
Avacta Group progresses to final cohort in Phase 1a study of AVA6000
Avacta Group plc (AIM: AVCT), a leader in the life sciences sector specializing in innovative oncology drugs and…
Primrose Bio emerges as biotech powerhouse, secures $15m from Ligand Pharmaceuticals
Primrose Bio, Inc. has been founded as a merger between Primordial Genetics, Inc. and Pelican Technology Holdings, Inc…
Lantern Pharma gets FDA nod for LP-284 clinical trial in non-Hodgkin’s lymphoma
Lantern Pharma Inc. (NASDAQ: LTRN), a trailblazer in artificial intelligence (AI) and machine learning (ML) for targeted cancer…
Astrea Bioseparations to boost US manufacturing capacity amid rising demand
Astrea Bioseparations (“Astrea Bio”), a leading provider of bioseparation and purification technologies, announced the significant expansion of its…
Sun Pharma secures marketing rights for stroke drug Tyvalzi from Pharmazz
Sun Pharmaceutical Industries Limited has entered into a license agreement with U.S.-based biopharmaceutical company Pharmazz Inc. for the…
Charles River, Related Sciences team up for AI-driven drug discovery
Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences have announced a multi-program collaboration valued at an…
Edgewise Therapeutics initiates EDG-7500 Phase 1 trial targeting cardiac diseases
Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a biopharmaceutical company specializing in muscle diseases, announced the commencement of its Phase…